The new metabolic treatments for sarcopenia
- 4 April 2013
- journal article
- review article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 25 (2) , 119-127
Abstract
In terms of managing sarcopenia, many studies have shown that physical activity (in particular resistance exercise) and specific nutrition interventions such as protein and amino acids supplementation can improve muscle mass and strength in older adults. Moreover, several drugs have been suggested to have an impact on muscle outcomes, with various levels of scientific evidence. In the present paper we have reviewed the evidence regarding the effect of some new metabolic agents (vitamin D, leucine, β-hydroxy β-methylbutyrate, citrulline malate, ornithine, isoflavones) on sarcopenia and muscular outcomes in older adults. For each metabolic agent, we have also discussed the biological plausibility of the described effect.Keywords
This publication has 56 references indexed in Scilit:
- Current and Future Pharmacologic Treatment of SarcopeniaClinics in Geriatric Medicine, 2011
- Prevalence and Risk Factors of Sarcopenia Among Nursing Home Older ResidentsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Short-Term Heavy Resistance Training Eliminates Age-Related Deficits in Muscle Mass and Strength in Healthy Older MalesJournal of Strength & Conditioning Research, 2011
- A prospective study of the associations between 25‐hydroxy‐vitamin D, sarcopenia progression and physical activity in older adultsClinical Endocrinology, 2010
- Dietary protein recommendations and the prevention of sarcopeniaCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by β-hydroxy-β-methylbutyrateAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Vitamin D and neurocognitive dysfunction: Preventing “D”ecline?Molecular Aspects of Medicine, 2008
- A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signallingBiochemical Journal, 2007
- Six months of isoflavone supplement increases fat-free mass in obese–sarcopenic postmenopausal women: a randomized double-blind controlled trialEuropean Journal of Clinical Nutrition, 2007
- Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal womenMenopause, 2003